{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:01:59Z","timestamp":1787162519939,"version":"build-2736575974"},"reference-count":79,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["ID1061779"],"award-info":[{"award-number":["ID1061779"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","award":["International PhD Scholarship"],"award-info":[{"award-number":["International PhD Scholarship"]}],"id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Mutation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1002\/humu.23656","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T04:41:29Z","timestamp":1537591289000},"page":"1764-1773","source":"Crossref","is-referenced-by-count":46,"title":["Current review of\n                    <i>TP53<\/i>\n                    pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome"],"prefix":"10.1155","volume":"39","author":[{"given":"Cristina","family":"Fortuno","sequence":"first","affiliation":[{"name":"QIMR Berghofer Medical Research Institute; Herston Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"James","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre and Royal Melbourne Hospital Familial Cancer Centre; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-7897","authenticated-orcid":false,"given":"Amanda B.","family":"Spurdle","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute; Herston Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"issue":"17","key":"10.1002\/humu.23656-BIB0001|humu23656-cit-0001","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1111\/febs.13352","article-title":"Detection of novel germline mutations for breast cancer in non-BRCA1\/2 families","volume":"282","author":"Aloraifi","year":"2015","journal-title":"FEBS Journal"},{"issue":"3","key":"10.1002\/humu.23656-BIB0002|humu23656-cit-0002","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1399-0004.2008.01133.x","article-title":"A molecular approach for identifying individuals with Li-Fraumeni syndrome who have a limited family history","volume":"75","author":"Ang","year":"2009","journal-title":"Clinical Genetics"},{"key":"10.1002\/humu.23656-BIB0003|humu23656-cit-0003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12881-015-0169-y","article-title":"Germline TP53 mutational spectrum in French Canadians with breast cancer","volume":"16","author":"Arcand","year":"2015","journal-title":"BMC Medical Genetics"},{"issue":"3","key":"10.1002\/humu.23656-BIB0004|humu23656-cit-0004","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10549-007-9608-6","article-title":"Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families","volume":"108","author":"Arcand","year":"2008","journal-title":"Breast Cancer Research and Treatment"},{"issue":"12","key":"10.1002\/humu.23656-BIB0005|humu23656-cit-0005","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1001\/jamaoncol.2017.1968","article-title":"Baseline surveillance in Li-Fraumeni Syndrome using whole-body magnetic resonance imaging: A meta-analysis","volume":"3","author":"Ballinger","year":"2017","journal-title":"JAMA Oncology"},{"issue":"2","key":"10.1002\/humu.23656-BIB0006|humu23656-cit-0006","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0165-4608(02)00601-5","article-title":"Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and\/or ovarian cancer families","volume":"138","author":"Balz","year":"2002","journal-title":"Cancer Genetics and Cytogenetics"},{"issue":"21","key":"10.1002\/humu.23656-BIB0007|humu23656-cit-0007","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni Syndrome from TP53 mutation carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/humu.23656-BIB0008|humu23656-cit-0008","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10897-016-9985-2","article-title":"The clinical utility of next generation sequencing results in a community-based hereditary cancer risk program","volume":"26","author":"Bunnell","year":"2017","journal-title":"Journal of Genetic Counseling"},{"issue":"10","key":"10.1002\/humu.23656-BIB0009|humu23656-cit-0009","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.30498","article-title":"A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes","volume":"123","author":"Buys","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1002\/humu.23656-BIB0010|humu23656-cit-0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-009-0349-6","article-title":"Identification and characterization of two novel germ line p53 mutations in the non-LFS\/non-LFL breast cancer families in Chinese population","volume":"119","author":"Cao","year":"2010","journal-title":"Breast Cancer Research and Treatment"},{"issue":"3","key":"10.1002\/humu.23656-BIB0011|humu23656-cit-0011","doi-asserted-by":"crossref","first-page":"e57581","DOI":"10.1371\/journal.pone.0057581","article-title":"Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: A portrait of early-onset breast cancer in Brazil","volume":"8","author":"Carraro","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1002\/humu.23656-BIB0012|humu23656-cit-0012","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"Castera","year":"2014","journal-title":"European Journal of Human Genetics"},{"issue":"1","key":"10.1002\/humu.23656-BIB0013|humu23656-cit-0013","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10549-014-3195-0","article-title":"Inherited predisposition to breast cancer among African American women","volume":"149","author":"Churpek","year":"2015","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"10.1002\/humu.23656-BIB0014|humu23656-cit-0014","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10689-017-0004-z","article-title":"A multi-gene panel study in hereditary breast and ovarian cancer in Colombia","volume":"17","author":"Cock-Rada","year":"2017","journal-title":"Familial Cancer"},{"key":"10.1002\/humu.23656-BIB0015|humu23656-cit-0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cancergen.2017.01.002","article-title":"Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel","volume":"211","author":"Coffee","year":"2017","journal-title":"Cancer Genetics"},{"issue":"4","key":"10.1002\/humu.23656-BIB0016|humu23656-cit-0016","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer","volume":"33","author":"Couch","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/humu.23656-BIB0017|humu23656-cit-0017","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","article-title":"Associations between cancer predisposition testing panel genes and breast cancer","volume":"3","author":"Couch","year":"2017","journal-title":"JAMA Oncology"},{"issue":"2","key":"10.1002\/humu.23656-BIB0018|humu23656-cit-0018","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10549-017-4181-0","article-title":"Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients","volume":"163","author":"Crawford","year":"2017","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"10.1002\/humu.23656-BIB0019|humu23656-cit-0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN guidelines insights: Genetic\/familial high-risk assessment: Breast and ovarian, Version 2.2017","volume":"15","author":"Daly","year":"2017","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"12","key":"10.1002\/humu.23656-BIB0020|humu23656-cit-0020","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/humu.23320","article-title":"Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history","volume":"38","author":"Andrade","year":"2017","journal-title":"Human Mutation"},{"issue":"7","key":"10.1002\/humu.23656-BIB0021|humu23656-cit-0021","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","article-title":"Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment","volume":"1","author":"Desmond","year":"2015","journal-title":"JAMA Oncology"},{"issue":"4","key":"10.1002\/humu.23656-BIB0022|humu23656-cit-0022","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10897-014-9796-2","article-title":"Testing for hereditary breast cancer: Panel or targeted testing? Experience from a clinical cancer genetics practice","volume":"24","author":"Doherty","year":"2015","journal-title":"Journal of Genetic Counseling"},{"issue":"3","key":"10.1002\/humu.23656-BIB0023|humu23656-cit-0023","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/annonc\/mdv592","article-title":"Genetic testing in a cohort of young patients with HER2-amplified breast cancer","volume":"27","author":"Eccles","year":"2016","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/humu.23656-BIB0024|humu23656-cit-0024","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.18632\/oncotarget.12699","article-title":"The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?","volume":"8","author":"Eliade","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1002\/humu.23656-BIB0025|humu23656-cit-0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jmg.2005.036319","article-title":"Malignant transformation and new primary tumours after therapeutic radiation for benign disease: Substantial risks in certain tumour prone syndromes","volume":"43","author":"Evans","year":"2006","journal-title":"Journal of Medical Genetics"},{"issue":"2","key":"10.1002\/humu.23656-BIB0027|humu23656-cit-0027","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10689-015-9779-y","article-title":"The breast cancer immunophenotype of TP53-p.R337H carriers is different from that observed among other pathogenic TP53 mutation carriers","volume":"14","author":"Fitarelli-Kiehl","year":"2015","journal-title":"Familial Cancer"},{"issue":"8","key":"10.1002\/humu.23656-BIB0028|humu23656-cit-0028","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/humu.23553","article-title":"Improved, ACMG-Compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants","volume":"39","author":"Fortuno","year":"2018","journal-title":"Human Mutation"},{"issue":"4","key":"10.1002\/humu.23656-BIB0029|humu23656-cit-0029","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10689-009-9287-z","article-title":"The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30","volume":"8","author":"Ginsburg","year":"2009","journal-title":"Familial Cancer"},{"issue":"10","key":"10.1002\/humu.23656-BIB0030|humu23656-cit-0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jmg.2008.058958","article-title":"High frequency of de novo mutations in Li-Fraumeni syndrome","volume":"46","author":"Gonzalez","year":"2009","journal-title":"Journal of Medical Genetics"},{"issue":"8","key":"10.1002\/humu.23656-BIB0031|humu23656-cit-0031","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","article-title":"Beyond Li Fraumeni Syndrome: Clinical characteristics of families with p53 germline mutations","volume":"27","author":"Gonzalez","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/humu.23656-BIB0032|humu23656-cit-0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12920-017-0244-7","article-title":"Next-generation sequencing in familial breast cancer patients from Lebanon","volume":"10","author":"Jalkh","year":"2017","journal-title":"BMC Medical Genomics"},{"issue":"10","key":"10.1002\/humu.23656-BIB0033|humu23656-cit-0033","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1245\/s10434-015-4754-2","article-title":"Multigene panel testing detects equal rates of pathogenic BRCA1\/2 mutations and has a higher diagnostic yield compared to limited BRCA1\/2 analysis alone in patients at risk for hereditary breast cancer","volume":"22","author":"Kapoor","year":"2015","journal-title":"Annals of Surgical Oncology"},{"issue":"14","key":"10.1002\/humu.23656-BIB0034|humu23656-cit-0034","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1002\/humu.23656-BIB0035|humu23656-cit-0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ijc.30428","article-title":"Gene panel sequencing in familial breast\/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1\/2","volume":"140","author":"Kraus","year":"2017","journal-title":"International Journal of Cancer"},{"issue":"19","key":"10.1002\/humu.23656-BIB1035|humu23656-cit-1035","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment","volume":"32","author":"Kurian","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1002\/humu.23656-BIB0036|humu23656-cit-0036","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jmoldx.2016.03.005","article-title":"Detection of germline mutation in hereditary breast and\/or ovarian cancers by next-generation sequencing on a four-gene panel","volume":"18","author":"Kwong","year":"2016","journal-title":"Journal of Molecular Diagnostics"},{"issue":"8","key":"10.1002\/humu.23656-BIB0037|humu23656-cit-0037","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ejca.2005.11.032","article-title":"BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives","volume":"42","author":"Lalloo","year":"2006","journal-title":"European Journal of Cancer"},{"issue":"2","key":"10.1002\/humu.23656-BIB0038|humu23656-cit-0038","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/bcr3172","article-title":"Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1\/2 screening to early-onset breast cancer patients","volume":"14","author":"Lee","year":"2012","journal-title":"Breast Cancer Research"},{"issue":"4","key":"10.1002\/humu.23656-BIB0039|humu23656-cit-0039","first-page":"1062","article-title":"Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer","volume":"60","author":"Lehman","year":"2000","journal-title":"Cancer Research"},{"issue":"11","key":"10.1002\/humu.23656-BIB0040|humu23656-cit-0040","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1586\/14737140.2015.1090879","article-title":"Genetic risk assessment and prevention: The role of genetic testing panels in breast cancer","volume":"15","author":"Lerner-Ellis","year":"2015","journal-title":"Expert Review of Anticancer Therapy"},{"issue":"4","key":"10.1002\/humu.23656-BIB0041|humu23656-cit-0041","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?","volume":"71","author":"Li","year":"1969","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/humu.23656-BIB0042|humu23656-cit-0042","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jmedgenet-2015-103452","article-title":"Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families","volume":"53","author":"Li","year":"2016","journal-title":"Journal of Medical Genetics"},{"issue":"7","key":"10.1002\/humu.23656-BIB0043|humu23656-cit-0043","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.18632\/oncotarget.7027","article-title":"Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer","volume":"7","author":"Lin","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1002\/humu.23656-BIB0044|humu23656-cit-0044","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ijc.30771","article-title":"Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53","volume":"141","author":"Lolas Hamameh","year":"2017","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10.1002\/humu.23656-BIB0045|humu23656-cit-0045","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1136\/jmg.40.4.e34","article-title":"Germline TP53 mutations in breast cancer families with multiple primary cancers: Is TP53 a modifier of BRCA1?","volume":"40","author":"Martin","year":"2003","journal-title":"Journal of Medical Genetics"},{"issue":"8","key":"10.1002\/humu.23656-BIB0046|humu23656-cit-0046","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gim.2014.176","article-title":"Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1\/2-negative patients with early-onset breast cancer","volume":"17","author":"Maxwell","year":"2015","journal-title":"Genetics in Medicine"},{"issue":"4","key":"10.1002\/humu.23656-BIB0047|humu23656-cit-0047","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10689-012-9557-z","article-title":"Routine TP53 testing for breast cancer under age 30: Ready for prime time?","volume":"11","author":"McCuaig","year":"2012","journal-title":"Familial Cancer"},{"issue":"4","key":"10.1002\/humu.23656-BIB0048|humu23656-cit-0048","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/cncr.26377","article-title":"Early onset HER2-positive breast cancer is associated with germline TP53 mutations","volume":"118","author":"Melhem-Bertrandt","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/humu.23656-BIB0049|humu23656-cit-0049","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2015.01.537","article-title":"Hereditary predisposition to ovarian cancer, looking beyond BRCA1\/BRCA2","volume":"137","author":"Minion","year":"2015","journal-title":"Gynecologic Oncology"},{"issue":"7","key":"10.1002\/humu.23656-BIB0050|humu23656-cit-0050","doi-asserted-by":"crossref","first-page":"e69026","DOI":"10.1371\/journal.pone.0069026","article-title":"High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort","volume":"8","author":"Mitchell","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1002\/humu.23656-BIB0051|humu23656-cit-0051","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-016-4038-y","article-title":"Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel","volume":"161","author":"Moran","year":"2017","journal-title":"Breast Cancer Research and Treatment"},{"issue":"12","key":"10.1002\/humu.23656-BIB0052|humu23656-cit-0052","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1158\/0008-5472.CAN-09-0851","article-title":"Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study","volume":"70","author":"Mouchawar","year":"2010","journal-title":"Cancer Research"},{"issue":"4","key":"10.1002\/humu.23656-BIB0053|humu23656-cit-0053","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cge.12735","article-title":"Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing","volume":"90","author":"Ng","year":"2016","journal-title":"Clinical Genetics"},{"issue":"1","key":"10.1002\/humu.23656-BIB0054|humu23656-cit-0054","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10689-017-0002-1","article-title":"Next generation sequencing is informing phenotype: A TP53 example","volume":"17","author":"O'Shea","year":"2017","journal-title":"Familial Cancer"},{"issue":"2","key":"10.1002\/humu.23656-BIB0055|humu23656-cit-0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10549-016-3948-z","article-title":"Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity","volume":"159","author":"Pinto","year":"2016","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"10.1002\/humu.23656-BIB0056|humu23656-cit-0056","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/bjc.1991.44","article-title":"Mutations in p53 do not account for heritable breast cancer: A study in five affected families","volume":"63","author":"Prosser","year":"1991","journal-title":"British Journal of Cancer"},{"issue":"13","key":"10.1002\/humu.23656-BIB0057|humu23656-cit-0057","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.7314\/APJCP.2015.16.13.5211","article-title":"Targeted resequencing of 30 genes improves the detection of deleterious mutations in South Indian women with breast and\/or ovarian cancers","volume":"16","author":"Rajkumar","year":"2015","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"2","key":"10.1002\/humu.23656-BIB0058|humu23656-cit-0058","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10689-012-9509-7","article-title":"Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients","volume":"11","author":"Rashid","year":"2012","journal-title":"Familial Cancer"},{"issue":"1","key":"10.1002\/humu.23656-BIB0059|humu23656-cit-0059","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-012-2375-z","article-title":"Prevalence of germline TP53 mutations in HER2+ breast cancer patients","volume":"139","author":"Rath","year":"2013","journal-title":"Breast Cancer Research and Treatment"},{"issue":"3","key":"10.1002\/humu.23656-BIB0060|humu23656-cit-0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/jmedgenet-2017-104976","article-title":"Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome","volume":"55","author":"Renaux-Petel","year":"2018","journal-title":"Journal of Medical Genetics"},{"issue":"5","key":"10.1002\/humu.23656-BIB0061|humu23656-cit-0061","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genetics in Medicine"},{"issue":"19","key":"10.1002\/humu.23656-BIB0062|humu23656-cit-0062","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1200\/JCO.2014.56.0474","article-title":"Multigene panel testing: Planning the next generation of research studies in clinical cancer genetics","volume":"32","author":"Robson","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/humu.23656-BIB0063|humu23656-cit-0063","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10549-017-4291-8","article-title":"Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer","volume":"164","author":"Rummel","year":"2017","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"10.1002\/humu.23656-BIB0064|humu23656-cit-0064","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-015-3429-9","article-title":"HBOC multi-gene panel testing: Comparison of two sequencing centers","volume":"152","author":"Schroeder","year":"2015","journal-title":"Breast Cancer Research and Treatment"},{"issue":"10","key":"10.1002\/humu.23656-BIB0065|humu23656-cit-0065","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/gim.2015.212","article-title":"Improving performance of multigene panels for genomic analysis of cancer predisposition","volume":"18","author":"Shirts","year":"2016","journal-title":"Genetics in Medicine"},{"key":"10.1002\/humu.23656-BIB0066|humu23656-cit-0066","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41523-017-0024-8","article-title":"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","volume":"3","author":"Slavin","year":"2017","journal-title":"npj Breast Cancer"},{"issue":"8","key":"10.1002\/humu.23656-BIB0067|humu23656-cit-0067","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/gim.2015.166","article-title":"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing","volume":"18","author":"Susswein","year":"2016","journal-title":"Genetics in Medicine"},{"issue":"29","key":"10.1002\/humu.23656-BIB0068|humu23656-cit-0068","doi-asserted-by":"crossref","first-page":"47064","DOI":"10.18632\/oncotarget.16791","article-title":"Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer","volume":"8","author":"Tedaldi","year":"2017","journal-title":"Oncotarget"},{"issue":"13","key":"10.1002\/humu.23656-BIB0069|humu23656-cit-0069","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.2015.63.7454","article-title":"Panel testing for familial breast cancer: Calibrating the tension between research and clinical care","volume":"34","author":"Thompson","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"26","key":"10.1002\/humu.23656-BIB0070|humu23656-cit-0070","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1200\/JCO.2009.22.7967","article-title":"2009 version of the Chompret criteria for Li Fraumeni syndrome","volume":"27","author":"Tinat","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/humu.23656-BIB0071|humu23656-cit-0071","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"issue":"13","key":"10.1002\/humu.23656-BIB0072|humu23656-cit-0072","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer","volume":"34","author":"Tung","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/humu.23656-BIB0073|humu23656-cit-0073","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.critrevonc.2016.10.008","article-title":"Routine use of gene panel testing in hereditary breast cancer should be performed with caution","volume":"108","author":"Marcke","year":"2016","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"2","key":"10.1002\/humu.23656-BIB0074|humu23656-cit-0074","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1472-6483(10)62233-X","article-title":"Preimplantation diagnosis for p53 tumour suppressor gene mutations","volume":"2","author":"Verlinsky","year":"2001","journal-title":"Reproductive BioMedicine Online"},{"issue":"12","key":"10.1002\/humu.23656-BIB0075|humu23656-cit-0075","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","article-title":"Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer","volume":"295","author":"Walsh","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/humu.23656-BIB0076|humu23656-cit-0076","article-title":"Somatic TP53 variants frequently confound germ-line testing results","author":"Weitzel","year":"2017","journal-title":"Genetics in Medicine"},{"key":"10.1002\/humu.23656-BIB0078|humu23656-cit-0078","doi-asserted-by":"crossref","DOI":"10.1038\/npjgenmed.2015.3","article-title":"Inherited breast cancer predisposition in Asians: Multigene panel testing outcomes from Singapore","volume":"1","author":"Wong","year":"2016","journal-title":"npj Genomic Medicine"},{"issue":"4","key":"10.1002\/humu.23656-BIB0079|humu23656-cit-0079","doi-asserted-by":"crossref","first-page":"e0125571","DOI":"10.1371\/journal.pone.0125571","article-title":"Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1002\/humu.23656-BIB0080|humu23656-cit-0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10689-016-9951-z","article-title":"Recurrent TP53 missense mutation in cancer patients of Arab descent","volume":"16","author":"Zick","year":"2017","journal-title":"Familial Cancer"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.23656","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/humu.23656\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T11:55:57Z","timestamp":1672314957000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.23656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.23656","archive":["Portico"],"relation":{},"ISSN":["1059-7794"],"issn-type":[{"value":"1059-7794","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,3]]}}}